The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors

Author:

Butler Javed1,Hamo Carine E.1,Filippatos Gerasimos2,Pocock Stuart J.3,Bernstein Richard A.4,Brueckmann Martina56,Cheung Alfred K.7,George Jyothis T.58,Green Jennifer B.9,Januzzi James L.10,Kaul Sanjay11,Lam Carolyn S.P.12,Lip Gregory Y.H.13,Marx Nikolaus14,McCullough Peter A.15,Mehta Cyrus R.16,Ponikowski Piotr17,Rosenstock Julio18,Sattar Naveed19,Salsali Afshin20,Scirica Benjamin M.21,Shah Sanjiv J.22,Tsutsui Hiroyuki23,Verma Subodh24,Wanner Christoph25,Woerle Hans-Juergan5,Zannad Faiez26,Anker Stefan D.2728293031,

Affiliation:

1. Cardiology Division; Stony Brook University; Stony Brook NY USA

2. National and Kapodistrian University of Athens, School of Medicine; Attikon University Hospital; Athens Greece

3. Department of Medical Statistics; London School of Hygiene and Tropical Medicine; London UK

4. Department of Neurology; Feinberg School of Medicine of Northwestern University; Chicago IL USA

5. Boehringer Ingelheim Pharmaceuticals Inc.; Ingelheim Germany

6. Faculty of Medicine Mannheim; University of Heidelberg; Mannheim Germany

7. Division of Nephrology and Hypertension; University of Utah; Salt Lake City UT USA

8. Warwick Medical School; University of Warwick; UK

9. Duke Clinical Research Institute; Duke University School of Medicine; Durham NC USA

10. Division of Cardiology; Massachusetts General Hospital; Boston MA USA

11. Division of Cardiology; Cedars-Sinai Medical Center; Los Angeles CA USA

12. National Heart Centre Singapore and Duke-National University of Singapore; Singapore

13. Institute of Cardiovascular Science; University of Birmingham, UK, and Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University; Aalborg Denmark

14. Department of Internal Medicine I, Cardiology; RWTH Aachen University; Aachen Germany

15. Baylor Heart and Vascular Institute; Dallas TX USA

16. Harvard School of Public Health; Boston MA USA

17. Medical University; Clinical Military Hospital; Wroclaw Poland

18. Dallas Diabetes Research Center at Medical City and University of Texas Southwestern Medical Center; Dallas TX USA

19. BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK

20. Boehringer Ingelheim Pharmaceuticals Inc.; Ridgefield CT USA

21. TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital; Harvard Medical School; Boston MA USA

22. Division of Cardiology; Northwestern University Feinberg School of Medicine; Chicago IL USA

23. Department of Cardiovascular Medicine; Faculty of Medical Sciences, Kyushu University; Fukuoka Japan

24. Division of Cardiac Surgery, Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute of St. Michael's Hospital Departments of Surgery, and Pharmacology and Toxicology; University of Toronto; Toronto Ontario Canada

25. Division of Nephrology, Department of Medicine; University Hospital; Wurzburg Germany

26. Inserm CIC 1433, U 1116; Université de Lorraine and CHU; Nancy France

27. Department of Cardiology and Pneumology; University Medical Centre Göttingen; Göttingen Germany

28. Division of Cardiology and Metabolism; Department of Cardiology (CVK)

29. Berlin-Brandenburg Center for Regenerative Therapies (BCRT); Germany

30. Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) Berlin; Germany

31. Charité Universitätsmedizin Berlin; Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3